Cargando…
The potential role of incretin therapy in the hospital setting
Hyperglycemia has been associated with increased morbidity and mortality in hospitalized patients. Insulin has traditionally been the drug of choice for managing hyperglycemia in this setting, but carries a significant risk of hypoglycemia. Incretin-based therapies, including glucagon-like peptide-1...
Autores principales: | Macdonald, Jennifer J., Neupane, Shristi, Gianchandani, Roma Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469200/ https://www.ncbi.nlm.nih.gov/pubmed/28702223 http://dx.doi.org/10.1186/s40842-015-0005-5 |
Ejemplares similares
-
Incretin-based therapies
por: Stonehouse, Anthony H, et al.
Publicado: (2012) -
Pathogenesis and management of postprandial hyperglycemia: role of incretin-based therapies
por: Gerich, John
Publicado: (2013) -
Incretins in the Therapy of Diabetic Kidney Disease
por: Przezak, Agnieszka, et al.
Publicado: (2021) -
Socioeconomic aspects of incretin-based therapy
por: Karagiannis, Thomas, et al.
Publicado: (2023) -
Role of incretin‐based therapy in hospitalized patients with type 2 diabetes
por: Gracia‐Ramos, Abraham Edgar
Publicado: (2019)